Mary Ann Liebert Inc.: Mast Cell Expansion From Blood
September 19, 2019
September 19, 2019
NEW ROCHELLE, New York, Sept. 19 -- Mary Ann Liebert Inc. issued the following news release:
Mast cells are critically involved in immunity and immune disorders. However, they are rarely cultured ex vivo for experimental manipulation because of the difficulty in isolating useful numbers and limitations related to 2D culture. A new study reports the successful development of authenticated mast cells by culturing hematopoietic stem cells in an engineered 3D connective tissue matrix. T . . .
Mast cells are critically involved in immunity and immune disorders. However, they are rarely cultured ex vivo for experimental manipulation because of the difficulty in isolating useful numbers and limitations related to 2D culture. A new study reports the successful development of authenticated mast cells by culturing hematopoietic stem cells in an engineered 3D connective tissue matrix. T . . .